Shock

·MeSH: Shock, Septic

13 drugs in development·8 companies·3 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
giapreza	LA JOLLA PHARMACEUTICAL CO (LJPC)
GIAPREZA	Innoviva, Inc. (INVA)
GIAPREZA®	Innoviva, Inc. (INVA)
isoproterenol	NEXUS BIOPHARMA INC (NEXS)
isoproterenol	Amphastar Pharmaceuticals, Inc. (AMPH)
vasopressin	Amphastar Pharmaceuticals, Inc. (AMPH)

Phase 3(3)

Drug	Company
low titer whole blood	UNITED THERAPEUTICS Corp (UTHR)
Methylene Blue	ENANTA PHARMACEUTICALS INC (ENTA)
Standard Care	UNITED THERAPEUTICS Corp (UTHR)

Preclinical(2)

Drug	Company
hemoglobin-based artificial oxygen carriers	SANGUI BIOTECH INTERNATIONAL INC (SGBI)
sbt102	SANGUI BIOTECH INTERNATIONAL INC (SGBI)

Phase 1/Phase 2(1)

Drug	Company
istaroxime	WINDTREE THERAPEUTICS INC /DE/ (WINT)

Phase 4(1)

Drug	Company
Angiotensin-II	Innoviva, Inc. (INVA)

BioSniper tracks 13 drugs in development for Shock across 8 companies.

There are 3 clinical trials targeting Shock tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.